Biotech Transfer Week GenomeWeb News Premium Content Existing subscribers login here. Biotech Transfer Week is Now FREE - Everyone Can Subscribe!

Sepracor, UMass Sue Generic Drug Maker
For Allegedly Infringing Clarinex Patents

[October 1, 2008]

By Ben Butkus

The plaintiffs claim that PAI in August filed an abbreviated new drug application with the US Food and Drug Administration for a generic version of an oral syrup containing the active ingredient desloratadine, which is marketed as Clarinex by Schering-Plough. Schering obtained a license from Sepracor to sell the prescription drug in 1997.

Login | Subscribe